Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Valeo Pharma (VPHIF)

OTHER OTC:VPHIF

VPHIF

Valeo Pharma

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding VPHIF?

Track your performance easily

Link Broker

Valeo Pharma (VPHIF) Income Statement

14 Followers

Valeo Pharma Income Statement

Last quarter (Q1 2024), Valeo Pharma's total revenue was C$13.54M, an increase of 2.86% from the same quarter last year. In Q1, Valeo Pharma's net income was C$-6.87M. See Valeo Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Oct 23	Oct 22	Oct 21	Oct 20	Oct 19
Total Revenue	C$ 54.29M	C$ 53.91M	C$ 27.75M	C$ 13.56M	C$ 7.47M	C$ 6.58M
Cost of Revenue	C$ 42.71M	C$ 40.94M	C$ 21.02M	C$ 9.60M	C$ 6.09M	C$ 5.18M
Gross Profit	C$ 11.57M	C$ 12.97M	C$ 6.72M	C$ 3.96M	C$ 1.38M	C$ 1.40M
Operating Expense	C$ 29.71M	C$ 30.04M	C$ 25.15M	C$ 16.65M	C$ 5.68M	C$ 5.14M
Operating Income	C$ -18.14M	C$ -17.07M	C$ -18.42M	C$ -12.69M	C$ -4.30M	C$ -3.74M
Net Non Operating Interest Income Expense	C$ -10.67M	C$ -10.07M	C$ -6.33M	C$ 1.39M	C$ 613.00K	C$ -134.00K
Other Income Expense	C$ -727.00K	C$ -149.00K	C$ -315.00K	C$ -153.00K	C$ 152.00K	C$ 256.00K
Pretax Income	C$ -28.43M	C$ -27.81M	C$ -26.92M	C$ -14.23M	C$ -4.76M	C$ -3.62M
Tax Provision	-	-	C$ -1.17M	-	-	C$ 0.00
Earnings From Equity Interest Net Of Tax	C$ -138.00K	C$ -200.00K	C$ -142.00K	-	-	-
Net Income Common Stockholders	C$ -28.43M	C$ -27.81M	C$ -25.75M	C$ -14.23M	C$ -4.76M	C$ -3.62M
Basic EPS	C$ -0.33	C$ -0.32	C$ -0.32	C$ -0.20	C$ -0.08	C$ -0.07
Diluted EPS	C$ -0.33	C$ -0.32	C$ -0.32	C$ -0.20	C$ -0.08	C$ -0.07
Basic Average Shares	C$ 349.71M	C$ 86.12M	C$ 80.86M	C$ 69.93M	C$ 57.91M	C$ 49.59M
Diluted Average Shares	C$ 349.71M	C$ 86.12M	C$ 80.86M	C$ 69.93M	C$ 57.91M	C$ 49.59M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 52.29M	C$ 70.98M	C$ 46.17M	C$ -26.25M	C$ -11.77M	C$ 10.31M
Net Income From Continuing And Discontinued Operation	C$ -28.43M	C$ -27.81M	C$ -25.75M	C$ -14.23M	C$ -4.76M	C$ -3.62M
Normalized Income	C$ -22.65M	C$ -20.44M	C$ -26.87M	C$ -10.21M	C$ -3.46M	C$ -3.62M
Interest Expense	-	-	-	-	-	C$ 110.00K
EBIT	C$ -17.66M	C$ -17.58M	C$ -20.42M	C$ -12.88M	C$ -4.16M	C$ -3.50M
EBITDA	C$ -14.99M	C$ -14.96M	C$ -19.00M	C$ -12.13M	C$ -3.74M	C$ -3.37M

Currency in CAD

Valeo Pharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing